Emergency Vaccination Programmes Reduce Infectious Disease Deaths By Nearly 60% Since 2000

Emergency vaccination initiatives have significantly reduced deaths from five major diseases by about 60% over 23 years, a new study reveals. These programmes also prevented a similar number of infections. Vaccinations have been crucial in curbing larger outbreaks of diseases like Ebola, cholera, and yellow fever.

The economic advantages of these vaccination efforts are substantial, estimated at $32 billion. This figure primarily reflects the prevention of deaths and the reduction in years lost to disability. However, researchers suggest this might underestimate total savings since it doesn't account for the costs associated with managing broader outbreaks or the economic disruptions from severe health emergencies.

The research, reported by BBC, is the first to thoroughly evaluate emergency vaccination responses to outbreaks of Ebola, measles, cholera, yellow fever, and meningitis. It examined 210 incidents from 2000 to 2023 across 49 countries. The findings indicate that vaccine roll-outs have effectively reduced deaths and cases by nearly 60%, while also preventing wider outbreaks.

Gavi, the vaccine alliance responsible for many programmes, supported this study. Dr Sania Nishtar, Gavi's CEO, emphasised the importance of rapid vaccine deployment: "For the first time, we are able to comprehensively quantify the benefit, in human and economic terms, of deploying vaccines against outbreaks of some of the deadliest infectious diseases."

Importance of Funding for Future Protection

Dr Nishtar highlighted that vaccines serve as a cost-effective measure against increasing outbreak risks. She stressed the need for full funding for Gavi to continue safeguarding communities over the next five years. Currently, Gavi seeks new funding amidst global foreign aid cuts.

The 2014 Ebola outbreak exemplifies potential costs without vaccines; it cost West African nations over $53 billion before an approved vaccine was available. This underscores the critical role vaccines play in mitigating both human and economic impacts during health crises.

With inputs from WAM